Toll-like receptor 5-dependent immunogenicity and protective efficacy of a recombinant fusion protein vaccine containing the nontoxic domains of Clostridium difficile toxins A and B and Salmonella enterica serovar typhimurium flagellin in a mouse mo
about
The potential for emerging therapeutic options for Clostridium difficile infectionImmunogenicity and protective efficacy of recombinant Clostridium difficile flagellar protein FliCThe roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection.Flagellin as carrier and adjuvant in cocaine vaccine development.A chimeric protein comprising the glucosyltransferase and cysteine proteinase domains of toxin B and the receptor binding domain of toxin A induces protective immunity against Clostridium difficile infection in mice and hamsters.Immunogenicity and protective efficacy of Clostridium difficile spore proteins.Carboxyl-terminal fusion of E7 into Flagellin shifts TLR5 activation to NLRC4/NAIP5 activation and induces TLR5-independent anti-tumor immunity.Clostridium difficile infection in the twenty-first century.Overview of Clostridium difficile infection: implications for ChinaAn overview of adjuvant formulations and delivery systems.Vaccines against Clostridium difficile.Immunoenhancement with flagellin as an adjuvant to whole-killed rabies vaccine in mice.Characterization of structural and immunological properties of a fusion protein between flagellin from Salmonella and lumazine synthase from Brucella.DNA Vaccine-Encoded Flagellin Can Be Used as an Adjuvant Scaffold to Augment HIV-1 gp41 Membrane Proximal External Region Immunogenicity.Novel Chimeric Protein Vaccines Against Infection
P2860
Q28082059-CDD2A6C0-D298-4C92-8F53-B319E8B18F90Q34512085-B4CB72D9-46DB-4B7A-8A54-DBB101FE6697Q34623572-0A4DA7AB-A542-44E0-8A33-608326483F39Q35057556-8C8286E7-8373-4886-97F8-6808B2BAD960Q36255845-D35DC127-B264-4F11-BCAE-1BC64153A072Q36630071-01B02543-B786-47C9-BE21-0C10EC4FEA09Q36785164-7EE85B85-90EF-4AE6-BECC-89B3FD03A859Q37289567-914F2745-5481-4384-9922-D44EB4368D85Q37609133-C10F7876-08D2-48F7-BFD5-5DB697539929Q38126953-981A71EA-C952-4842-95A9-4983FEA4BEFDQ38196682-4607B35D-BFB7-4E78-8C2C-BBBB15A3433EQ40877967-FADBA5B4-2A0A-4D82-9DD5-390BAF015F44Q49954533-F738A479-0167-4314-90F6-958106D7EC8CQ52729536-3539B57D-C5BC-4F2E-8620-0F54421CD2C8Q58580396-8476100C-0C6E-4557-9BA4-1258D120AE2E
P2860
Toll-like receptor 5-dependent immunogenicity and protective efficacy of a recombinant fusion protein vaccine containing the nontoxic domains of Clostridium difficile toxins A and B and Salmonella enterica serovar typhimurium flagellin in a mouse mo
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Toll-like receptor 5-dependent ...... murium flagellin in a mouse mo
@en
type
label
Toll-like receptor 5-dependent ...... murium flagellin in a mouse mo
@en
prefLabel
Toll-like receptor 5-dependent ...... murium flagellin in a mouse mo
@en
P2093
P2860
P921
P356
P1476
Toll-like receptor 5-dependent ...... murium flagellin in a mouse mo
@en
P2093
Chandrabali Ghose
Ciarán P Kelly
David D Ho
Janneke M Verhagen
Olivia Chenesseau
Xinhua Chen
Yaoxing Huang
P2860
P304
P356
10.1128/IAI.01074-12
P407
P577
2013-04-01T00:00:00Z